Dow Pharmaceutical Sciences, Inc.
Develops topical formulations for pharmaceutical and biotech companies
Petaluma, CA
NYSE: VRX
Contact: Jim Currie
Acquisition
Acquired by: Valeant Pharmaceuticals International
Exit date: December 10, 2008
Case Study
Dow Pharmaceutical Sciences specializes in development of topical drug products for pharmaceutical and biotechnology clients
Essex Woodlands initially invested in Dow Pharmaceuticals in 2005. …
Learn More